NCT05827887 An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants Status COMPLETED Phase N/A
NCT05822752 Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05821855 A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05818709 A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participants Status COMPLETED Phase PHASE3
NCT05814627 Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05791526 An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan Status COMPLETED Phase N/A
NCT05785715 Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT05783609 Epcoritamab and Rituximab for First-line Follicular Lymphoma Status RECRUITING Phase PHASE2
NCT05782907 Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05782127 Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05771428 Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT05768711 Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05763459 A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT05760313 A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide Status COMPLETED Phase PHASE2
NCT05753501 Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05748483 Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05744401 A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT05741034 A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese Participants Status COMPLETED Phase PHASE3
NCT05738850 Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants Status COMPLETED Phase PHASE1